Such difference in xenografts developed from DU145/sh-E2F1 and DU145/sh-ICAM-1 cells demonstrated the opposing effects between E2F1 and ICAM-1 in tumorigenesis of prostate cancer. This evidence concerns the gene E2F1 and prostate cancer.